<VariationArchive VariationID="94320" VariationName="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs)" VariationType="Duplication" Accession="VCV000094320" Version="20" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="100220" VariationID="94320">
      <GeneList>
        <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
          </Location>
          <OMIM>603009</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs)</Name>
      <CanonicalSPDI>NC_000002.12:71612666:CCCCCCC:CCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71612666" stop="71612667" display_start="71612666" display_stop="71612667" variantLength="1" positionVCF="71612666" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71839796" stop="71839797" display_start="71839796" display_stop="71839797" variantLength="1" positionVCF="71839796" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>I1419fs</ProteinChange>
      <ProteinChange>I1388fs</ProteinChange>
      <ProteinChange>I1433fs</ProteinChange>
      <ProteinChange>I1401fs</ProteinChange>
      <ProteinChange>I1402fs</ProteinChange>
      <ProteinChange>I1418fs</ProteinChange>
      <ProteinChange>I1387fs</ProteinChange>
      <ProteinChange>I1432fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.71839803dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.71839803dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.71612673dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.71612673dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008694.1" sequenceAccession="NG_008694" sequenceVersion="1" change="g.164051dup">
            <Expression>NG_008694.1:g.164051dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130455.2" sequenceAccession="NM_001130455" sequenceVersion="2" change="c.4203dup">
            <Expression>NM_001130455.2:c.4203dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123927.1" sequenceAccession="NP_001123927" sequenceVersion="1" change="p.Ile1402fs">
            <Expression>NP_001123927.1:p.Ile1402fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130976.2" sequenceAccession="NM_001130976" sequenceVersion="2" change="c.4158dup">
            <Expression>NM_001130976.2:c.4158dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124448.1" sequenceAccession="NP_001124448" sequenceVersion="1" change="p.Ile1387fs">
            <Expression>NP_001124448.1:p.Ile1387fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130977.2" sequenceAccession="NM_001130977" sequenceVersion="2" change="c.4158dup">
            <Expression>NM_001130977.2:c.4158dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124449.1" sequenceAccession="NP_001124449" sequenceVersion="1" change="p.Ile1387fs">
            <Expression>NP_001124449.1:p.Ile1387fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130978.2" sequenceAccession="NM_001130978" sequenceVersion="2" change="c.4200dup">
            <Expression>NM_001130978.2:c.4200dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124450.1" sequenceAccession="NP_001124450" sequenceVersion="1" change="p.Ile1401fs">
            <Expression>NP_001124450.1:p.Ile1401fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130979.2" sequenceAccession="NM_001130979" sequenceVersion="2" change="c.4293dup">
            <Expression>NM_001130979.2:c.4293dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124451.1" sequenceAccession="NP_001124451" sequenceVersion="1" change="p.Ile1432fs">
            <Expression>NP_001124451.1:p.Ile1432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130980.2" sequenceAccession="NM_001130980" sequenceVersion="2" change="c.4251dup">
            <Expression>NM_001130980.2:c.4251dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124452.1" sequenceAccession="NP_001124452" sequenceVersion="1" change="p.Ile1418fs">
            <Expression>NP_001124452.1:p.Ile1418fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130981.2" sequenceAccession="NM_001130981" sequenceVersion="2" change="c.4251dup">
            <Expression>NM_001130981.2:c.4251dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124453.1" sequenceAccession="NP_001124453" sequenceVersion="1" change="p.Ile1418fs">
            <Expression>NP_001124453.1:p.Ile1418fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130982.2" sequenceAccession="NM_001130982" sequenceVersion="2" change="c.4296dup">
            <Expression>NM_001130982.2:c.4296dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124454.1" sequenceAccession="NP_001124454" sequenceVersion="1" change="p.Ile1433fs">
            <Expression>NP_001124454.1:p.Ile1433fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130983.2" sequenceAccession="NM_001130983" sequenceVersion="2" change="c.4203dup">
            <Expression>NM_001130983.2:c.4203dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124455.1" sequenceAccession="NP_001124455" sequenceVersion="1" change="p.Ile1402fs">
            <Expression>NP_001124455.1:p.Ile1402fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130984.2" sequenceAccession="NM_001130984" sequenceVersion="2" change="c.4161dup">
            <Expression>NM_001130984.2:c.4161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124456.1" sequenceAccession="NP_001124456" sequenceVersion="1" change="p.Ile1388fs">
            <Expression>NP_001124456.1:p.Ile1388fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130985.2" sequenceAccession="NM_001130985" sequenceVersion="2" change="c.4254dup">
            <Expression>NM_001130985.2:c.4254dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124457.1" sequenceAccession="NP_001124457" sequenceVersion="1" change="p.Ile1419fs">
            <Expression>NP_001124457.1:p.Ile1419fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130986.2" sequenceAccession="NM_001130986" sequenceVersion="2" change="c.4161dup">
            <Expression>NM_001130986.2:c.4161dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124458.1" sequenceAccession="NP_001124458" sequenceVersion="1" change="p.Ile1388fs">
            <Expression>NP_001124458.1:p.Ile1388fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130987.2" sequenceAccession="NM_001130987" sequenceVersion="2" change="c.4254dup" MANESelect="true">
            <Expression>NM_001130987.2:c.4254dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124459.1" sequenceAccession="NP_001124459" sequenceVersion="1" change="p.Ile1419fs">
            <Expression>NP_001124459.1:p.Ile1419fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.4200dup" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.4200dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003485.1" sequenceAccession="NP_003485" sequenceVersion="1" change="p.Ile1401fs">
            <Expression>NP_003485.1:p.Ile1401fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.3" sequenceAccession="NM_003494" sequenceVersion="3" change="c.4200dupC">
            <Expression>NM_003494.3:c.4200dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_845" sequenceAccession="LRG_845">
            <Expression>LRG_845:g.164051dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t2" sequenceAccession="LRG_845t2">
            <Expression>LRG_845t2:c.4254dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p2" sequenceAccession="LRG_845p2" change="p.Ile1419fs">
            <Expression>LRG_845p2:p.Ile1419fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t1" sequenceAccession="LRG_845t1">
            <Expression>LRG_845t1:c.4200dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p1" sequenceAccession="LRG_845p1" change="p.Ile1401fs">
            <Expression>LRG_845p1:p.Ile1401fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.4200dupC" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.4200dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.4193_4194insC" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.4193_4194insC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA222163" DB="ClinGen" />
        <XRef Type="rs" ID="398123786" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND Qualitative or quantitative defects of dysferlin" Accession="RCV000537543" Version="8">
        <ClassifiedConditionList TraitSetID="9586">
          <ClassifiedCondition DB="MedGen" ID="C2931687">Qualitative or quantitative defects of dysferlin</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND not provided" Accession="RCV000790760" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2B" Accession="RCV000984262" Version="5">
        <ClassifiedConditionList TraitSetID="1850">
          <ClassifiedCondition DB="MedGen" ID="C1850889">Autosomal recessive limb-girdle muscular dystrophy type 2B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2018-12-03" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND Distal myopathy with anterior tibial onset" Accession="RCV002283453" Version="1">
        <ClassifiedConditionList TraitSetID="1849">
          <ClassifiedCondition DB="MedGen" ID="C1847532">Distal myopathy with anterior tibial onset</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND multiple conditions" Accession="RCV002490697" Version="1">
        <ClassifiedConditionList TraitSetID="10241">
          <ClassifiedCondition DB="MedGen" ID="C1850889">Autosomal recessive limb-girdle muscular dystrophy type 2B</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1847532">Distal myopathy with anterior tibial onset</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551973">Miyoshi muscular dystrophy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs) AND Miyoshi muscular dystrophy 1" Accession="RCV003466984" Version="2">
        <ClassifiedConditionList TraitSetID="1848">
          <ClassifiedCondition DB="MedGen" ID="C4551973">Miyoshi muscular dystrophy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-24" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2016-12-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16100712</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16891820</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17698709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18853459</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19528035</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DYSF</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301480</ID>
          <ID Source="BookShelf">NBK1303</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1850" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2988" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                <XRef ID="MONDO:0009676" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD3</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8574" />
                <XRef ID="8574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="268" DB="Orphanet" />
              <XRef ID="C1850889" DB="MedGen" />
              <XRef ID="MONDO:0009676" DB="MONDO" />
              <XRef Type="MIM" ID="253601" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9484" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                <XRef ID="MONDO:0016145" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2003" />
                <XRef ID="2003" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="207073" DB="Orphanet" />
              <XRef ID="C2931687" DB="MedGen" />
              <XRef ID="MONDO:0016145" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1849" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Distal myopathy with anterior tibial onset</ElementValue>
                <XRef ID="MONDO:0011721" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DMAT</ElementValue>
                <XRef Type="MIM" ID="606768" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17080" />
                <XRef ID="17080" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="178400" DB="Orphanet" />
              <XRef ID="C1847532" DB="MedGen" />
              <XRef ID="MONDO:0011721" DB="MONDO" />
              <XRef Type="MIM" ID="606768" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1848" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2959" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                <XRef ID="MONDO:0024545" DB="MONDO" />
                <XRef ID="C118846" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD1</ElementValue>
                <XRef Type="MIM" ID="254130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="45448" DB="Orphanet" />
              <XRef ID="C4551973" DB="MedGen" />
              <XRef ID="MONDO:0024545" DB="MONDO" />
              <XRef Type="MIM" ID="254130" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10241" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2959" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                <XRef ID="MONDO:0024545" DB="MONDO" />
                <XRef ID="C118846" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD1</ElementValue>
                <XRef Type="MIM" ID="254130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="45448" DB="Orphanet" />
              <XRef ID="C4551973" DB="MedGen" />
              <XRef ID="MONDO:0024545" DB="MONDO" />
              <XRef Type="MIM" ID="254130" DB="OMIM" />
            </Trait>
            <Trait ID="2988" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2B</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2B/4237" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603009.0022" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2B</ElementValue>
                <XRef ID="MONDO:0009676" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD3</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR2</ElementValue>
                <XRef Type="MIM" ID="253601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8574" />
                <XRef ID="8574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="268" DB="Orphanet" />
              <XRef ID="C1850889" DB="MedGen" />
              <XRef ID="MONDO:0009676" DB="MONDO" />
              <XRef Type="MIM" ID="253601" DB="OMIM" />
            </Trait>
            <Trait ID="3419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Distal myopathy with anterior tibial onset</ElementValue>
                <XRef ID="MONDO:0011721" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DMAT</ElementValue>
                <XRef Type="MIM" ID="606768" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17080" />
                <XRef ID="17080" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="178400" DB="Orphanet" />
              <XRef ID="C1847532" DB="MedGen" />
              <XRef ID="MONDO:0011721" DB="MONDO" />
              <XRef Type="MIM" ID="606768" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2235472" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="230256|OMIM:253601" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132387" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19528035</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16891820</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GC" referenceAllele="G" start="71839796" stop="71839796" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253601" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2868043" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_003494.4:c.4200dupC|Limb-girdle muscular dystrophy type 2B" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001452768" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4200dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Limb-girdle muscular dystrophy type 2B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5030761" SubmissionDate="2022-09-04" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="2-71839796-G-GC" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002573143" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16891820</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.004%). Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000094320 / PMID: 16891820 / 3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003690" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003202" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001130987.2:c.4254dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606768" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12013725</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5456552" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_003494.4:c.4200dup|OMIM:253601;254130;606768" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811619" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4200dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253601" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254130" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606768" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7333826" SubmissionDate="2023-05-05" DateLastUpdated="2023-05-13" DateCreated="2023-05-13">
        <ClinVarSubmissionID localKey="SUB13279829" submittedAssembly="hg19" title="SUB13279829" />
        <ClinVarAccession Accession="SCV003922071" DateUpdated="2023-05-13" DateCreated="2023-05-13" Type="SCV" Version="1" SubmitterName="Lifecell International Pvt. Ltd" OrgID="507720" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">16891820</ID>
          </Citation>
          <Comment>A Homozygote Frameshift variant c.4193_4194insC in Exon 39 of the DYSF gene that results in the amino acid substitution p.Ile1401fs*8 was identified. The observed variant has a minor allele frequency of 0.00006% in gnomAD exomes and novel in gnomAD genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic [Variation ID: 94320]. The observed variation has been reported previously in individual(s) with Miyoshi muscular dystrophy, limb-girdle muscular dystrophy, and intermediate phenotypes (Cho HJ, et.al., 2006). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF">
              <Name>dysferlin</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003494.4:exon 39</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs398123786" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4193_4194insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253601" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13279829</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7927392" SubmissionDate="2024-02-06" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="NM_003494.4:c.4200dupC|not provided" />
        <ClinVarAccession Accession="SCV004243109" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital" OrgID="505691" OrganizationCategory="laboratory" OrgAbbreviation="GM4113, RH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4200dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14210317</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7844866" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_003494.4:c.4200dup|OMIM:254130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194240" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4200dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1373701" SubmissionDate="2017-06-30" DateLastUpdated="2019-07-31" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="49205_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000701299" DateUpdated="2019-07-31" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000331300" DateChanged="2019-08-06" Version="2">
            <Comment Type="MergeComment">SCV000331300 was merged into SCV000701299 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000229967" DateChanged="2019-08-06" Version="3">
            <Comment Type="MergeComment">SCV000229967 was merged into SCV000701299 to remove duplication.</Comment>
          </Replaced>
          <Replaced Accession="SCV000342868" DateChanged="2018-02-14" Version="2" />
          <Replaced Accession="SCV000112181" DateChanged="2017-03-31" Version="3" />
        </ReplacedList>
        <Classification DateLastEvaluated="2016-06-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="CC" referenceAllele="C" start="71839803" stop="71839803" variantLength="1" />
            <GeneLocation>NM_001130978.1:Ex39</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI053023" />
            <XRef DB="dbSNP" ID="398123786" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">23757202</ID>
        </Citation>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DYSF</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL001</SubmissionName>
          <SubmissionName>EGL002</SubmissionName>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>PILOT_TEST_03</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2297680" SubmissionDate="2019-10-03" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="DX_1|OMIM:253601" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164466" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18853459</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16891820</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17698709</ID>
          </Citation>
          <Comment>The heterozygous p.Ile1419HisfsTer8 variant (sometimes described as p.Ile1401HisfsTer8) in DYSFwas identified by our study in the compound heterozygous state, with a VUS, in one individual with limb-girdle muscular dystrophy (LGMD). This variant has been identified in 0.01335% (2/14978) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs762804655). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency and it has been reported pathogenic in ClinVar (Variation ID: 94320). The p.Ile1419HisfsTer8 variant in DYSF has been reported in 1 Moroccan, 1 Korean, and 6 unknown individuals with LGMD, including 3 individuals homozygous and 3 individuals heterozygous for the variant (PMID: 18853459, 16891820, 17698709). The presence of this variant in combination with a variant (reported pathogenic in ClinVar) and in an individual with LGMD increases the likelihood that the p.Ile1419HisfsTer8 variant is pathogenic (PMID: 18853459). This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 1419 and leads to a premature termination codon 8 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the DYSF gene is an established disease mechanism in autosomal recessive LGMD, and this is a loss of function variant. In summary, this variant meets criteria to be classified as pathogenic for LGMD in an autosomal recessive manner based on the predicted impact of the variant and multiple reports of pathogenicity in ClinVar. ACMG/AMP Criteria applied: PM2, PVS1, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>WGS</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GC" referenceAllele="G" start="71839796" stop="71839796" variantLength="1" />
          </Location>
          <OtherNameList>
            <Name>p.Ile1419HisfsTer8</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253601" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6387569</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1242222" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1368939|MedGen:C2931687" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000649683" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17698709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301480</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16100712</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16891820</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17698709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18853459</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19528035</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile1401Hisfs*8) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Miyoshi muscular dystrophy, limb-girdle muscular dystrophy, and intermediate phenotypes (PMID: 16100712, 16891820, 17698709, 18853459, 19528035). ClinVar contains an entry for this variant (Variation ID: 94320). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.71839796_71839797insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931687" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7844866" TraitType="Disease" MappingType="XRef" MappingValue="254130" MappingRef="OMIM">
        <MedGen CUI="C4551973" Name="Miyoshi muscular dystrophy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5030761" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003202" MappingRef="HP">
        <MedGen CUI="C0541794" Name="Muscular atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1373701" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456552" TraitType="Disease" MappingType="XRef" MappingValue="253601" MappingRef="OMIM">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2235472" TraitType="Disease" MappingType="XRef" MappingValue="253601" MappingRef="OMIM">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456552" TraitType="Disease" MappingType="XRef" MappingValue="254130" MappingRef="OMIM">
        <MedGen CUI="C4551973" Name="Miyoshi muscular dystrophy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2868043" TraitType="Disease" MappingType="Name" MappingValue="Limb-girdle muscular dystrophy type 2B" MappingRef="Preferred">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2297680" TraitType="Disease" MappingType="XRef" MappingValue="253601" MappingRef="OMIM">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1242222" TraitType="Disease" MappingType="XRef" MappingValue="C2931687" MappingRef="MedGen">
        <MedGen CUI="C2931687" Name="Qualitative or quantitative defects of dysferlin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456552" TraitType="Disease" MappingType="XRef" MappingValue="606768" MappingRef="OMIM">
        <MedGen CUI="C1847532" Name="Distal myopathy with anterior tibial onset" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7333826" TraitType="Disease" MappingType="XRef" MappingValue="253601" MappingRef="OMIM">
        <MedGen CUI="C1850889" Name="Autosomal recessive limb-girdle muscular dystrophy type 2B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5030761" TraitType="Disease" MappingType="XRef" MappingValue="606768" MappingRef="OMIM">
        <MedGen CUI="C1847532" Name="Distal myopathy with anterior tibial onset" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5030761" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003690" MappingRef="HP">
        <MedGen CUI="C0587246" Name="Limb muscle weakness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7927392" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2018-03-22">SCV000331301</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

